Risk Assessment

Mar 23, 2017 by in ONCOLOGY Comments Off on Risk Assessment

where p = probability. While the concept is intuitive, it is easy to forget that the denominator can be just as important as the numerator in determining the final relative risk (RR)….

read more

Systemic Therapy

Mar 23, 2017 by in ONCOLOGY Comments Off on Systemic Therapy

98. Stewart HJ, Forrest AP, Everington D, et al. Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group….

read more

Digital Breast Tomosynthesis

Mar 23, 2017 by in ONCOLOGY Comments Off on Digital Breast Tomosynthesis

Fig. 9.1 A large 10cm IDC is occult on 2D mammography but well demonstrated on CEMRI imaging in this woman with dense breasts Fig. 9.2 A 2cm. spiculated IDC is…

read more

The Sick Lobe Concept

Mar 23, 2017 by in ONCOLOGY Comments Off on The Sick Lobe Concept

Fig. 3.1 Lobar growth pattern in diffusely growing in situ breast carcinoma. (a) Magnetic resonance imaging, (b) the same image with diseased area marked, (c) corresponding large-format histology section of…

read more

Surgical Management of the Axilla

Mar 23, 2017 by in ONCOLOGY Comments Off on Surgical Management of the Axilla

Clinical circumstances Recommendations for use of sentinel node biopsy Level of evidence T1 or T2 tumors Acceptable Good T3 or T4 tumors Not recommended Insufficient Multicentric tumors Acceptable Limited Inflammatory…

read more

The Surgical Management of Invasive Breast Cancer

Mar 23, 2017 by in ONCOLOGY Comments Off on The Surgical Management of Invasive Breast Cancer

Darius S. Francescatti and Melvin J. Silverstein (eds.)Breast Cancer2014A New Era in Management10.1007/978-1-4614-8063-1_16© Springer Science+Business Media New York 2014 16. The Surgical Management of Invasive Breast Cancer Beth C. Freedman1, Alyssa Gillego2 and Susan K. Boolbol3   (1) Department of Breast…

read more

RF Therapy

Mar 23, 2017 by in ONCOLOGY Comments Off on RF Therapy

Trial Year Disease N Treatment Complete ablation Complications Jeffrey et al. [15] 1999 T3–T4 breast cancer or tumors >5 cm 5 Intraoperative RFA—mastectomy 80 % None Izzo et al. [16]…

read more
Get Clinical Tree app for offline access